Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

A “Tipping Point” For Response To Anti-Microbial Resistance

This article was originally published in RPM Report

Executive Summary

FDA’s Acting Commissioner Stephen Ostroff addressed the ASM Conference on Antimicrobial Resistance in Zoonotic Bacteria and Foodborne Pathogens on May 8. He began by noting it had been three years since the last meeting of the group – and highlighted how much has changed in the level of attention to address antimicrobial resistance in the interim.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS079855

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel